Targeting IRAK3 for Degradation to Enhance IL-12 Pro-inflammatory Cytokine Production
| Autor: | Ann Rowley, Brian S. Brown, Mary Stofega, Hana Hoh, Rebecca Mathew, Violeta Marin, Rong-Xian Ding, Ryan A. McClure, Fabiola M. Bittencourt, Jun Chen, Tarikere Gururaja, Taisei Kinoshita, Xueqing Wang, Alexey Rivkin, Kevin R. Woller |
|---|---|
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | ACS Chemical Biology. 17:1315-1320 |
| ISSN: | 1554-8937 1554-8929 |
| DOI: | 10.1021/acschembio.2c00037 |
| Popis: | Interleukin-1 receptor-associated kinase 3 (IRAK3) is a pseudokinase mediator in the human inflammatory pathway, and ablation of its function is associated with enhanced antitumor immunity. Traditionally, pseudokinases have eluded "druggability" and have not been considered tractable targets in the pharmaceutical industry. Herein we disclose a CRISPR/Cas9-mediated knockout of IRAK3 in monocyte-derived dendritic cells that results in an increase in IL-12 production upon lipopolysaccharide (LPS) stimulation. Furthermore, we disclose and characterize Degradomer D-1, which displays selective proteasomal degradation of IRAK3 and reproduces the 1L-12p40 increases observed in the CRISPR/Cas9 knockout. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|